COMMUNIQUÉS West-GlobeNewswire
-
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/05/2026 -
Stryker to participate in the Bank of America Securities 2026 Global Healthcare Conference
01/05/2026 -
Eton Pharmaceuticals relaunches HEMANGEOL® (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution
01/05/2026 -
Phathom Pharmaceuticals to Highlight VOQUEZNA® (vonoprazan) at DDW 2026 Annual Meeting
01/05/2026 -
Weight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide)
01/05/2026 -
Vaxart to Host Stockholder Fireside Chat on May 8 at 4:30 p.m. ET
01/05/2026 -
Nova Leap Health Corp. announces Closing of Strategic Acquisition in Nova Scotia
01/05/2026 -
Noema Pharma to Present Phase 2a Results for Cendifensine in Vasomotor Symptoms (Hot Flashes) Due to Menopause at the 2026 ACOG Annual Clinical & Scientific Meeting
01/05/2026 -
InVitria Showcases Exbumin® and Optibumin® 25 at IPEC Excipient World: Biologics Summit: Recombinant Human Serum Albumins Already Used in On-Market Approved Biologics
01/05/2026 -
Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
01/05/2026 -
Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
01/05/2026 -
Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026
01/05/2026 -
Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants
01/05/2026 -
MemoPryl Under Investigation (2026 Official Website Scam WARNING Update) Avoid Fake Complaints & Hidden Risks
01/05/2026 -
YD Bio Limited Reports Full Year 2025 Financial Results
01/05/2026 -
SteelPower Capsules for Male Enhancement Support: Review the Ingredients & Where to Buy to Avoid Complaints
01/05/2026 -
Leanzene Gummies Under Investigation (2026 Official Website Scam WARNING Update) Avoid Fake Complaints & Hidden Risks
01/05/2026 -
InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow
01/05/2026 -
CORRECTION: Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health
01/05/2026
Pages